Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion type Assertion NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_head.
- NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion wasGeneratedBy ECO_0000203 NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_provenance.
- NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion wasDerivedFrom befree-2016 NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_provenance.
- NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion SIO_000772 23069641 NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_provenance.
- NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion evidence source_evidence_literature NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_provenance.
- NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_assertion description "[BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021323.RAPo2Tf98MoiKPQdRNk0-IoRMen2Q5Ah48j2TBHh5iNBU130_provenance.